ReviewDiagnostics (Basel, Switzerland)2026
Practical Guide to Percutaneous Biopsy with Contrast-Enhanced Mammography: From Planning to Post-Procedural Management.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Contrast-enhanced mammography-guided biopsy (CEM-guided biopsy) is an emerging minimally invasive technique for the diagnosis of enhancing breast lesions visible only after contrast administration. Traditionally, these lesions required magnetic resonance imaging (MRI)-guided biopsy, which may be limited by high costs, reduced accessibility, prolonged procedure times, and patient-related contraindications. This review aims to provide a practical and updated overview of CEM-guided biopsy, focusing on procedural workflow, technical execution, patient preparation, and complication management in daily clinical practice. A narrative review of the current literature on CEM-guided biopsy was performed, focusing on technical feasibility, procedural protocols, patient management, diagnostic performance, and reported complications. This review integrates evidence from recent clinical studies and practical considerations derived from interventional breast imaging practice. Early clinical experiences demonstrate high technical success rates for CEM-guided biopsy, with procedure times generally shorter than those reported for MRI-guided biopsy. However, formal measures of diagnostic accuracy have not been consistently reported across the available studies. Key procedural aspects include pre-procedural imaging evaluation, contrast administration timing, lesion targeting on recombined images, patient positioning, vacuum-assisted biopsy techniques, and post-procedural care. Reported complication rates are low and comparable to those of conventional stereotactic biopsy procedures. CEM-guided biopsy represents a promising alternative to MRI-guided breast biopsy, offering a faster, more accessible, and well-tolerated approach for sampling enhancing-only breast lesions. Although current evidence remains limited and heterogeneous, this technique may facilitate wider implementation of contrast-enhanced image-guided breast interventions. Standardized protocols and larger multicenter studies are still needed to validate its broader clinical role.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.